MRTFA Knockout Cell Line (HEK293)

The choice depends on whether you are studying MRTFA (MKL1, MAL)'s role as an actin-monomer-sensitive SRF transcriptional coactivator or its functions in mechanotransduction and cancer biology. The Knockout line is the standard tool for asking whether MRTFA is required for these processes — MRTFA is retained in the cytoplasm by binding to monomeric G-actin; upon actin polymerization (reducing G-actin), MRTFA translocates to the nucleus and binds SRF to activate transcription of cytoskeletal and contractile genes. Overexpression is useful for studying MRTFA in heterologous expression contexts. For mechanobiology research, the EDITGENE MRTFA Knockout in HEK293 enables study of actin-SRF transcriptional signaling — MRTFA-SRF responds to mechanical cues, serum stimulation, RhoA activation, and other inputs that affect actin dynamics. MRTFB (MKL2) paralog expression should be assessed given functional overlap. Rescue with wild-type, actin-binding-deficient (RPEL motif mutations), or constitutively nuclear MRTFA enables comprehensive structure-function studies. The knockout is a critical specificity control for MRTF inhibitors (CCG-203971, CCG-257081) in cancer and fibrosis drug development.

Primary applications: • Actin-SRF transcription: SRF reporter assays and target gene (SRF, ACTA2, MYH11, CYR61) expression analysis following serum stimulation, RhoA activation, or mechanical stimulation. • Mechanotransduction: substrate stiffness-induced gene expression studies given MRTFA's mechanosensitive nuclear translocation. • Nuclear translocation imaging: subcellular localization analysis of epitope-tagged MRTFA under different actin dynamic conditions. • MRTF inhibitor specificity: critical genetic control for CCG-203971, CCG-257081, and other MRTF/SRF pathway inhibitors in cancer and fibrosis drug development. EDITGENE recommends this model for researchers investigating actin-SRF mechanotransduction, MRTFA-mediated transcription, and MRTF-targeted therapeutic development.

Yes. MRTFA rescue experiments require attention to actin-binding architecture: • Construct design: use a codon-modified MRTFA sequence with a small C-terminal tag (FLAG, HA). MRTFA has N-terminal RPEL motifs (three G-actin binding), B1 SAP domain, and C-terminal transactivation domain — preserve all elements. • Actin-binding-deficient rescue: RPEL motif mutations disrupt G-actin binding, generating constitutively nuclear MRTFA — invaluable for studying actin-independent transcription. • Constitutively cytoplasmic rescue: nuclear localization signal mutations retain MRTFA in cytoplasm regardless of actin status. • Functional readout: rescue should restore actin-responsive SRF activity, particularly serum-induced or RhoA-activated nuclear translocation and target gene expression. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.